MiniMed Group, Inc.
18.34USD
+0.0500 (+0.27%)
Not enough data yet
A reading needs 5 members, each at least 14 days old with a track record on this site (simulated portfolios and calls), who shared a take in the last 30 days; 2 of them need a strong record.
Sign in to share your take on MMED.
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | — | 2.5B | 2.7B | 3.1B | 3.4B | 3.7B |
| Q1 | — | — | — | 723.0M | 843.0M | — |
| Q2 | — | — | — | — | 824.4M | — |
| Q3 | — | — | 687.0M | 790.0M | 860.6M | — |
| Q4 | — | — | 724.0M* | 837.0M* | — | — |
Revenue
| (USD) | 2023 | 2024 | 2025 | 2026 | 2027 | 2028 |
|---|---|---|---|---|---|---|
| FY | — | -.440 | -.840 | -1.30 | .700 | .694 |
| Q1 | — | — | — | -.080 | .000 | — |
| Q2 | — | — | — | — | .101 | — |
| Q3 | — | — | -.040 | -.470 | .205 | — |
| Q4 | — | — |
Fiscal period: Reported, Estimated. Reported figures: SEC filings (EDGAR). Estimates are sell-side consensus for periods that have not reported. Cells marked * were synthesized from the annual filing less the year-to-date figures, because the quarter was not filed on its own. Earnings per share are restated onto today's share basis, so a period before a stock split is comparable with the ones after it.
Revenue to net income
| -.680* |
| -.721* |
| — |
| — |
Debt level and coverage